Skip to content

Public urged to sign up for Covid drug trial

Over-50s and younger adults with underlying health conditions are being urged to participate in a study of life-saving treatments for COVID-19.

The study is open to those who test positive for Covid and had symptoms develop in the previous five days. Volunteers will be given pills to take at home.

The study will help decide how antiviral drugs will be used, Prof Sir Jonathan Van-Tam, the deputy chief medical officer for England, said.

Health Secretary Sajid Javid asked everyone eligible to "step forward" and "help us to learn more about medicines which could save thousands of lives".

Antivirals were "part of our approach as we learn to live with Covid, by preventing the most vulnerable from being hospitalised", he said.

The UK regulator has licensed both for treating Covid, with molnupiravir the first to be given the green light, in November. Both have completed clinical trials and shown promising results at reducing the risk of serious illness or death.

Launched in December, it already has 4,500 people signed up but needs 6,000 more as soon as possible.

You can sign up at the study website now or your GP may contact you to ask you to participate if you test positive for Covid.

Read full story

Source: BBC News, 25 January 2022

User Feedback

Recommended Comments

There are no comments to display.

Create an account or sign in to comment

Registered address: Patient Safety Learning, China Works SB203, 100 Black Prince Road Vauxhall, London, SE1 7SJ

Account

Navigation

Search

Search

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.